Cargando…
Metallothioneins as dynamic markers for brain disease in lysosomal disorders
OBJECTIVE: To facilitate development of novel disease-modifying therapies for lysosomal storage disorder (LSDs) characterized by nervous system involvement such as metachromatic leukodystrophy (MLD), molecular markers for monitoring disease progression and therapeutic response are needed. To this en...
Autores principales: | Cesani, Martina, Cavalca, Eleonora, Macco, Romina, Leoncini, Giuseppe, Terreni, Maria Rosa, Lorioli, Laura, Furlan, Roberto, Comi, Giancarlo, Doglioni, Claudio, Zacchetti, Daniele, Sessa, Maria, Scherzer, Clemens R, Biffi, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237725/ https://www.ncbi.nlm.nih.gov/pubmed/24242821 http://dx.doi.org/10.1002/ana.24053 |
Ejemplares similares
-
Astrocytes acquire resistance to iron-dependent oxidative stress upon proinflammatory activation
por: Macco, Romina, et al.
Publicado: (2013) -
Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes
por: Lee, Sook-Jeong, et al.
Publicado: (2010) -
Shaping mechanisms of metal specificity in a family of metazoan metallothioneins: evolutionary differentiation of mollusc metallothioneins
por: Palacios, Òscar, et al.
Publicado: (2011) -
Structure of mammalian metallothionein.
por: Kägi, J H, et al.
Publicado: (1984) -
The roles of metallothioneins in carcinogenesis
por: Si, Manfei, et al.
Publicado: (2018)